SPOTLIGHT -
June 3rd 2024
Rakesh Jain, MD, shares more about the recent approval of Austedo XR for the treatment of tardive dyskinesia and Huntington disease chorea control.
May 30th 2024
The FDA has approved Austedo XR as a once-daily pill treatment option for tardive dyskinesia and Huntington disease chorea control.
May 22nd 2024
Check out new data from phase 3 study of Ingrezza for the real-world management of tardive dyskinesia.
May 7th 2024
Here are highlights from the third day of this year’s APA Annual Meeting.
May 6th 2024
New research on tardive dyskinesia has also been featured at the 2024 APA Annual Meeting.